藥物成份

共有 20983 個藥物成份

R1 Anti-PCT-Ab~biotin (gray cap), 1 bottle, 9 mL: Biotinylated monoclonal anti-PCT antibody (mouse) 2.0 μg/mL; phosphate buffer 95 mmol/L, pH 7.5; preservative.

• 關聯藥證數量: 1

R1 Antibody reagent in vial A and B (liquid).

• 關聯藥證數量: 1

R1 Antibody reagent in vial A and B (liquid). Anti-phenytoin monoclonal antibody (mouse).R2=SR Tracer reagent in vial C (liquid). Fluorescein-labeled phenytoin derivative.

• 關聯藥證數量: 1

R1 Chlorophosphonazo Ⅲ in vial A and B (liquid).R2=SR EDTA in vial C (liquid).

• 關聯藥證數量: 1

R1 Citric acid:200 mmol/L; thiourea:115 mmol/L; detergentR2 Sodium ascorbate:150 mmol/L; FerroZine:6 mmol/L;preservative

• 關聯藥證數量: 1

R1 Conjugated amphetamine, methamphetamine, and MDMA derivatives;\n buffer; bovine serum albumin; 0.09 % sodium azide\nR2 Microparticles attached to amphetamine, methamphetamine, and\n MDMA antibodies (mouse monoclonal); buffer; bovine serum albumin;\n 0.09 % sodium azide\n

• 關聯藥證數量: 1

R1 Glycylglycine 110 mmol/L\n Tris buffer 130 mmol/L\nR2 r-glutamyl-p-nitroanililde 21 mmol/L\n Citric acid buffer 15 mmol/L

• 關聯藥證數量: 1

R1 Imidazole buffer: 123 mmol/L, pH 6.5 (37°C); EDTA: 2.46 mmol/L;\n Mg2+: 12.3 mmol/L; ADP: 2.46 mmol/L; AMP: 6.14 mmol/L;\n Diadenosine pentaphosphate: 19μmol/L; NADP (yeast): 2.46 mmol/L;\n N-acetylcysteine: 24.6 mmol/L; HK (yeast) ≧ 36.7 μkat/L; G6P-DH (E.coli):\n≧ 23.4 μkat/L.\nR2 CAPSO buffer: 20 mmol/L, pH 8.8 (37°C); glucose: 120 mmol/L;\n EDTA: 2.46 mmol/L; creatine phosphate: 184 mmol/L.\n

• 關聯藥證數量: 1

R1 Phosphate buffer: 200 mmol/L, GOD\n >= 183 ukat/L; POD>= 0.33 ukat/L; 4- aminophenazone:\n0.77 mmol/L; phenol: 11 mmol/L\n

• 關聯藥證數量: 1

R1 Sulfamic acid 70 mmol/L HCl 70 mmol/LR2 3.5-DCPD 5 mmol/L

• 關聯藥證數量: 1

R1 TRIS buffer: 50 mmol/L, pH 8.0; PEG: 4.2 %; EDTA: 2.0 mmol/L; preservative\nR2 Polyclonal anti-human albumin antibodies (sheep): dependent on titer;\n TRIS buffer: 100 mmol/L, pH 7.2; preservative\n Antigen Excess Reagent (for ACN 8253):\nR3 Albumin in diluted serum (human); NaCl: 150 mmol/L; phosphate\n buffer: 50 mmol/L, pH 7.0; preservative\n

• 關聯藥證數量: 1

R1 Tris buffer: ≧ 0.2 mol/l, pH 8.45; Ferrous ammonium sulfate: ≧ 8.4 μmol/l; Hydroxylamine hydrochloride: ≧0.1 mol/l; Nonionic surfactant: thiourea; Dilute sulfuric acidR2 FerroZine: 20.3 mmol/l; Preservative

• 關聯藥證數量: 1

R1 (Bottles 1,1a and 2)\n Citrate buffer: 150 mmol/L, pH 4.8；1-naphthyl phosphate:12.1 mmol/L；fast red TR salt: 1.2mmol/L；1,5-pentanediol:220 mmol/L；3.3mL/L；preservative.(Additionally for non-prostatic acid phosphatase determination: sodium tartrate:100 mmol/L)\n3 Acetic acid: 0.8 mol/L

• 關聯藥證數量: 1

R1 Alkaline buffer in vial B (liquid).

• 關聯藥證數量: 1

R1 Anti-IgM T antiserum (rabbit) specific for human\n IgM in phosphate buffer stabilized with 0.09% sodium azide in vial B (liquid).\n\nR2 Reagent for antigen excess check.\n IgM in diluted serum (human) stabilized with 0.09% sodium azide in vial C (liquid).\n

• 關聯藥證數量: 1

R1 Blank：Sodium hydroxide,EDTA-Na in vial A (liquid)\nR2=SR U/CSF Reagent：Benzethonium chloride in vial C (liquid)

• 關聯藥證數量: 1

R1 Buffer, preservatives

• 關聯藥證數量: 1

R1 Conjugate Reagent Gentamicin conjugate; piperazine-N, N-bis (ethanesulfonic acid) (PIPES) buffer pH 7.2; preservative. \nR2 Latex-Antibody Reagent Anti-gentamicin antibody (mouse monoclonal); latex microparticle; 3-(N-morpholino) propane sulfonic acid (MOPS) buffer pH 7.5; stabilizer; preservative.

• 關聯藥證數量: 1

R1 Conjugate Working Solution\n Conjugated methadone derivative in buffer.\nR2 Antibody/Microparticle Working Soltuion\n Microparticles attached to methadone antibody \n (mouse monoclonal).

• 關聯藥證數量: 1

R1 EA Solution enzyme acceptor (microbial): 0.22 g/l; anti-tobramycin antibody (mouse monoclonal): 25.5 mg/l; 3-(N-morpholino) propanesulfonic acid (MOPS) buffer; buffer salts; surfactant; carrier protein.R2 E D Solutionenzyme donor (microbial)-tobramycin: 23.4 μg/l; chlorophenol red-β-D-galactopyranoside: 2.4 g/l; goat anti-mouse antibodies: 3.3 g/l; 3-(N-morpholino) propanesulfonic acid (MOPS) buffer salts, surfactant

• 關聯藥證數量: 1

R1 H. influenzae type b latex:\nAnti-H. influenzae type b serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1 g/l).\nR2 Streptococcus pneumoniase omhi type latex:\nAnti-S. pneumoniae serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1g/l).\nR3 Neissria meningitides group A latex:\nAnti-N. meningitides A serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1 g/l). \nR4 Neisseria meningitides group B/ Escherichia coli K1 latex:\nAnti-N. meningitides B monoclonal antibody (mouse) (sodium merthiolate 0.2 g/l+sodium azide 1 g/l). \nR5 Neisseria meningitides group C latex:\nAnti-N. meningitides C serum (rabbit) (sodium merthiolate 0.2 g/l+sodium azide 1g/l). \nR6 Positive control: (lyophilized)\nAntigen extracts of H. influenzae b, S.pneumoniae, N.meningitides A, C, E.coli K1 (sodium merthiolate 0.1 g/l). \n

• 關聯藥證數量: 1

R1 HEPES buffer: 10.07 mmol/L; CHES: 96.95 mmol/L; dextran sulfate: 1.5g/L; magnesium nitrate hexahydrate: ≧11.7 mmol/L; HSDA: 0.96 mmol/L; ascorbate oxdase(Eupenicillium sp., recombinant)≧ 50 μkat/L (3.0 kU/L); peroxidase ≧16.7 μkat/L (1.0 kU/L).R2 HEPES buffer: 10.07 mmol/L,pH 7.0 ; PEG-cholesterol esterase (Pseudomonas spec.) ≧3.33 μkat/L(0.2 kU/L); PEG-cholesterol oxidase (Streptomyces sp., recombinant) ≧127 μkat/L (7.6 kU/L); peroxidase(horseradish)≧ 333 μkat/L (20 kU/L); 4-amino-antipyrine:2.46 mmol/LR2 HEPES buffer: 10.07 mmol/l; PEG-cholesterol oxidase > 127 μkat/l (7.6 kU/l); peroxidase > 333 μkat/l (20 kU/l); 4-amino-antipyrine:2.46 mmol/l\n

• 關聯藥證數量: 1

R1 HEPES buffer: 52.5 mmol/L, pH 7 (37˚C); sodium chloride: 87 mmol/L; magnesium chloride: 12.6 mmol/L; calcium chloride: 0.075 mmol/L; α-glucosidase (microorganisma)≧4 kU/L; monoclonal antibodies (mouse): 97 mg/L R2 HEPES buffer: 52.5 mmol/L, pH 7 (37˚C); 4,6-ethylidene-G7PNP; 22 mmol/L

• 關聯藥證數量: 1

R1 HEPES, α-Glucosidase, Mg2+, sodium chloride, and Ethylidene-G7-PNP\nR2=SR HEPES, and Ethylidene-G7-PNP

• 關聯藥證數量: 1

R1 Imidazole buffer: 123 mmol/L, pH 6.5 (37°C); EDTA: 2.46 mmol/L; Mg2+: 12.3 mmol/L; ADP: 2.46 mmol/L; AMP: 6.14 mmol/L; diadenosine pentaphosphate: 19 μmol/L; NADP (yeast): 2.46 mmol/L; N-acetylcysteine: 24.6 mmol/L; HK (yeast): ≧36.7 μkat/L (25°C); G6P-DH (E.coli): ≧23.4 μkat/L (25°C); preservative; stabilizer; additive.\nR2 CAPSO buffer: 20 mmol/L, pH 8.8 (37°C); glucose: 120 mmol/L; Mg2+: 11 mmol/L; EDTA: 2.46 mmol/L; creatine phosphate: 184 mmol/L; 4 monoclonal anti-CK-M antibodies (mouse), inhibiting capacity: >99.6% up to 66.8 μkat/L (4000 U/L) (37°C) CK-M subunit; preservative; stabilizer; additive.

• 關聯藥證數量: 1

R1 MES buffer: 5.0 mmol/L, pH 6.0; Mg2+: 24 mmol/L; ATP: ≥ 4.5 mmol/L;\n NADP: ≥ 7.0 mmol/L; preservative\nR3 HEPES buffer: 200 mmol/L, pH 8.0; Mg2+: 4 mmol/L; HK (yeast):\n ≥ 300 μkat/L; G-6-PDH (E. coli): ≥ 300 μkat/L; preservative\n

• 關聯藥證數量: 1

R1 NaCl 9 %\nR2 TRIS buffer: 220 mmol/L, pH 8.6; 2-oxoglutarate: 73 mmol/L; NADH: 2.5 mmol/L; ADP: 6.5 mmol/L; urease (jack bean): ≥ 300 μkat/L; GLDH (bovine liver): ≥ 80 μkat/L; preservative; nonreactive stabilizers

• 關聯藥證數量: 1

R1 PIPES buffera:50 mmol/l, pH 6.8;Mg2+:40 mmol/l;sodium cholate: 0.20mmol/l;ATP≧1.4 mmol/l;4-aminophenazone≧0.13 mmol/l;4-chlorophenol:4.7 mmol/l; potassium hexacyanoferrate(II):1μmol/l;fatty alchol polyglycol ether: 0.65%;lipoprotein lipase(pseudomonas spec.)≧5.0 U/ml; glycerokinase(Bacillus stearothermophilus)≧0.19 U/ml; Glycerol phosphate oxidase (E. coli)≧2.5 U/ml; peroxidase (horseradish)≧0.10 U/ml; preservative a)PIPES=piperazine-N,N'-bis(2-ethanesulfonic acid)

• 關聯藥證數量: 1

R1 Phosphate buffer: 12.7 mmol/l, pH7.2；NaCl: 0.13 mol/l；PEG: 70 g/l；preservative\nR2 Anti-human ceruloplasmin antibody (rabbit): dependent on titer；NaCl: 0.1 mol/l；preservative

• 關聯藥證數量: 1

R1 Phosphate buffer: 60 mmol/L, pH 7.5; NaCl: 100 mmol/L;polyethylene glycol (PEG): 30g/L; preservative, in vial A (liquid).\nR2 Latex particles coated with polyclonal anti-human Lp(a) antibodies (rabbit); glycine buffer: 25 mmol/L, pH 9.6; preservative, in vial B (liquid).\n

• 關聯藥證數量: 1

R1 Phosphate buffer: 68 mmol/L, pH 7.5; α-ketobutyrate:3.7 mmol/L; preservative

• 關聯藥證數量: 1

R1 Phosphate buffer、NaCl、polyethylene glycol.\nR2 Anti-human transterrin antibodies (rabbit)、NaCl.

• 關聯藥證數量: 1

R1 Pyrophosphate buffer: 92 mmol/L, pH 7.7; potassium hexacyanoferrate (III): 2.4 mmol/L\nR2 GOODs buffer: 10 mmol/L, pH 4.0; butyrylthiocholine: 46 mmol/L; stabilizers.

• 關聯藥證數量: 1

R1 R2 R3Potassium 80 mmol/LHydroxide 900 mmol/LPhosphate 135 12 mmol/LPicric acid 50 4.4 mmol/L

• 關聯藥證數量: 1

R1 Saturating reagent in vial B (liquid). R2=SR FerroZine in vial C (liquid). Active ingredientsComponents Concentrations R1 R2 Test TRIS 375 150 Mmol/LFerrous chloride 62 25 mmol/LSodium hydrogen carbonate 75 30 μmol/LFerroZine 20 2.5 mol/LHydroxylamine 160 20 mol/LSodium azide 0.02 0.01 %PH 8.4 2.5 8.4 Reagent R1 contains a nonreactive stabilizer.

• 關聯藥證數量: 1

R1 Sodium hydroxide: 0.20 mol/l\nR2 Picric acid: 25 mmol/l

• 關聯藥證數量: 1

R1 Sodium hydroxide: 400 mmol/L; potassium sodium tartrate: 89 mmol/L

• 關聯藥證數量: 1

R1 Sulfamic acid 70 mmol/L\n HCl 70 mmol/L\n DMSO 5 mol/L\nR2 3.5-DCPD 5 mmol/L

• 關聯藥證數量: 1

R1 Sulfamic acid (H3NO3S): 110 mmol/L; sodium acetate buffer (C2H3NaO2):\n 85 mmol/L; surfactant; solubilizer\nR3 Diazonium ion: 3 mmol/L; HCl: 100 mmol/L\n

• 關聯藥證數量: 1

R1 TAPS buffer (N-Tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid): 30 mmol/L, pH 8.1;\n creatinase (microorganisms): ≥332 μkat/L; sarcosine oxidase (microorganisms):≥132 μkat/L;\nascorbate oxidase (microorganisms): ≥33 μkat/L; HTIB: 1.2 g/L; detergents; preservative\n \nR3 TAPS buffer: 50 mmol/L, pH 8.0; creatininase (microorganisms): ≥498 μkat/L;\n peroxidase (horseradish): ≥16.6 μkat/L; 4-aminophenazone: 0.5 g/L; potassium\n hexacyanoferrate (II): 60 mg/L; detergent; preservative\n

• 關聯藥證數量: 1

R1 TAPS** buffer: 30 mmol/L, pH 8.1: creatinase (microorganisms) ≧ 333 μkat/L; sarcosine oxidase (microorganisms) ≧ 133 μkat/L; ascorbate oxidase (microorganisms) ≧ 33 μkat/L; HTIB: 5.9 mmol/L; detergents; preservative.R2 TAPS** buffer: 50 mmol/L, pH 8.0; creatininase (microorganisms) ≧ 500 μkat/L; peroxidase (horseradish) ≧ 16.7 μkat/L; 4-aminophenazone: 2.0 mmol/L; potassium hexacyanoferrate (II): 163 μmol/L; detergent; preservative.**TAPS=3-[[tris(hydroxymethyl) methyl] amino] propanesulfonic acid.

• 關聯藥證數量: 1

R1 TRIS buffer: 100 mmol/L, pH 7.8; L-aspartate: 300 mmol/L; NADH (yeast): 0.23 mmol/L; MDH (porcine heart) ≧ 0.53 U/mL (8.83 μkat/L); LDH (microorganisms) ≧0.75 U/mL (12.5 μkat/L); \nR2 α-ketoglutarate: 75 mmol/L.

• 關聯藥證數量: 1

R1 TRIS buffer: 100 mmol/L, pH8.0; polyethylene glycol: 3.0%; in vial B.\nR2 Anti-human C3c antibody (goat): 33 mmol/L in vial C.

• 關聯藥證數量: 1

R1 TRIS buffer: 264 mmol/L, pH 7.8 (37 °C); L-aspartate:\n 792 mmol/L; MDH (microorganism): ≥ 24 μkat/L; LDH\n (microorganisms): ≥ 48 μkat/L; albumin (bovine):\n 0.25 %; preservative\nBottle Pyridoxal phosphate\nR3 = cobas c pack NADH: ≥ 1.7 mmol/L; 2-oxoglutarate: 94 mmol/L\nposition C ;preservative\n

• 關聯藥證數量: 1

R1 TRIS buffer: 400 mmol/L, pH 7.8; L-aspartate: 1200 mmol/L; NADH (yeast): 0.91 mmol/L; MDH (porcine hear) ≧ 2.1 U/mL (35 μkat/L); LDH (microorganisms) ≧3.0 U/mL (50 μkat/L); preservative.\nR2 α-Ketoglutarate: 75 mmol/L; preservative.

• 關聯藥證數量: 1

R1 TRIS buffer: 50 mmol/L, pH 8.0; PEG: 4.2%; detergent; preservative.\nR2 Anti-human apolipoprotein B antibodies (sheep): dependent on titer; TRIS buffer: 100 mmol/L, pH 8.0: preservative.

• 關聯藥證數量: 1

R1 TRIS buffera: 100 mmol/L, polyethylene glycol: 3.0%\nR2 Anti-human C4 antibody dependent on titer; TRIS buffer: 33 mmol/L

• 關聯藥證數量: 1

R1 TRIS buffer：100 mmol/L,pH7.8;Mg2+：4 mmol/L;ATP≧1.7 mmol/L;NADP≧1.0 mmol/L;preservative\nR2 HEPES buffer：30 mmo/L,pH7.0; Mg2+：4 mmol/L;HK≧8.3U/mL(yeast);G-6-PDH≧15U/mL(E.coli); preservative\n

• 關聯藥證數量: 1

R1 TRIS buffer：100 mmol/L， pH8.0; polyethylene glycol：3.0%；preservative in vial B (liquid)\n\nR2 Anti-human C4 antibody (goat)：dependent on titer； TRIS buffer：33 mmol/L；preservative in vial C(liquid)

• 關聯藥證數量: 1

R1 TRIS*/6-aminocaproic acid buffer: 500 mmol/L, pH 11.25;EGTA:90 μmol/L; preservativeR2 Xylidyl blue:0.28 mmol/L; detergent, preservative*TRIS=Tris(hydroxymethyl)-aminomethane

• 關聯藥證數量: 1

R1 TRIS*buffer:123 mmol/L,pH 8.25; glycylglycine:123 mmol/l;preservative, additiveR2 Acetate buffer:10 mmol/l,pH 4.5; L-y-glutamyl-3-carboxy-4-nitroanilide:25 mmol/l;preservative, stabilizer*TRIS=tris(hydroxymethyl)-aminomethane

• 關聯藥證數量: 1

R1 Tris Buffer 80 mmol/L\n MDH > 600 U/L\n L-aspartate 240 mmol/L\n a-ketoglutaric acid 12 mmol/L\nR2 Tris Buffer 80 mmol/L\n NADH 0.18 mmol/L

• 關聯藥證數量: 1

R1 Tris buffer pH 8.0 80 mmol/l\n 2-oxoglutarate 15 mmol/l\nR2 Urease >100 U/ml\n GLDH 6000 U/l\n NADH 0.32 mmol/l\nR4 Urea 50 mg/dL (8.33 mmol/L) \n

• 關聯藥證數量: 1

R1 (1.5 mL) Group B Streptococcus latex\nR2 (1.5 mL) Negative control latex\nR3 (0.5 mL) Positive control\n10 disposable cards with 6 reaction fields\n50 disposable stirrers

• 關聯藥證數量: 1

R1 (3 x 21 mL): TRIS 100 mmol/L、Polyethylene Glycol 35 g/L、Sodium Azide 0.1%。\nR2 (3 x 9 mL)：Anti-human apolipoprotein A1 goat serum 50%、TRIS 100 mmol/L、Sodium Azide 0.1%。\nCAL: 1×1 mL。\nCAL DILUENT: 2×2 mL。

• 關聯藥證數量: 1

R1 (Bottles 1 and 1a)\n TRIS buffer: 125 mmol/L, pH 7.3; L-alanine: 625 mmol/L; NADH (yeast): 0.23 mmol/L; LDH (microorganisms): ≧ 1.5 U/mL (25.0 μkat/L); preservative

• 關聯藥證數量: 1

R1 (Bottles 1 and 1a)\nPhosphate buffer：60.7 mmol/L,pH7.7; 5,5-dithiobisnitrobenzoic acid：0.30 mmol/L;preservative\nR2 (Bottles 2 and 2a)\nButyrylthiocholine iodide：42.5 mmol/L;preservative

• 關聯藥證數量: 1

R1 (Buffer Reagent): Tris (hydroxymethyl) aminomethane (100mM)R2 (Antiserum Reagent): Anti-human α1-AT goat antiserum (75%)

• 關聯藥證數量: 1

R1 (Buffer solution): citric acid monohydrate 21 mg/ml, EDTA·2Na 0.37 mg/ml, tetradecyl-trimethyl-ammonium bromide 25 mg/ml\nR2 (Nitrous acid solution): sodium nitrate 0.345 mg/ml\nCalibrator (#929 6031): human serum containing ditauro-bilirubin\n

• 關聯藥證數量: 1

R1 2-Amino-2-methyl-1-propanol: 1.724 mol/L, pH 10.5 (30 ℃); magnesium acetate: 3.83 mmol/L; zinc sulfate: 0.766 mmol/L; N-(2-hydroxyethyl)-ethylenediamine triacetic acid: 3.83 mmol/L\nSR p-nitrophenyl phosphate: 132.8 mmol/L, pH 8.5 (30 ℃); preservatives

• 關聯藥證數量: 1

R1 2-Amino-2-methyl-1-propanol：1.12 mol/L,pH 10.44(30℃);magnesium acetate：2.49 mmol/L;zinc sulfate：0.50 mmol/L;\nN-(2-hydroxyethyl)-ethylenediamine triacetic acid：2.49 mmol/L\nR2 p-Nitrophenyl phosphate：99.5 mmol/L,pH8.50(25℃);preservatives.

• 關聯藥證數量: 1

R1 2-amino-2-methyl-1-propanol: 1.724 mol/L, pH 10.44(30°C); magnesium acetate:3.83 mmol/L, zinc sulfate:0.766 mmol/L; N-(2-hydroxyethyl)-ethylenediamine triacetic acid:3.83 mmol/L\nR3 p-nitrophenyl phosphate: 132.8 mmol/L, pH 8.44(30°C); preservatives\n

• 關聯藥證數量: 1

R1 : ( PEPC (microbial) >9.25 μkat/L ) ; ( MDH (porcine) >92.5 μkat/L ) ; NADH analog 0.8 mmol/L ; PEP >16.7 mmol/L.) buffer ; stabilizer ; preservative

• 關聯藥證數量: 1

R1 : Buffer\n Ethanolamine Buffer 0.69 mol/l, pH 10.6\nR2 : Chromogen\n O-Cresolphthalein 0.09 mmol/l\n Complexone \n 8-Hydroxyquinoline 3.8 mmol/l\n Hydrochloric acid 34 mmol/l\n

• 關聯藥證數量: 1

R1 : N-ethyl-N-(2-sulphophenylenmethyl)-m-toluidine \n Peroxidase(POD : extracted from Horseradish) \n Ascorbate oxidase(ASOD : extracted from Cucurbita sp.)\n PBS buffer\nR2 : uricase(extracted from Candide sp.)\n 4-Amino-antipyrine(4-AAP)\n Phosphate-borate buffer

• 關聯藥證數量: 1

R1 : Phosphate buffer 40 mmol/l\nR2 : Heat aggregated human IgG ≦0.08 mg/ml

• 關聯藥證數量: 1

R1 : Substrate Slide ; \nC1 : Positive Control ; \nC0 : Negative Control. ;\nR2 : Universal FITC Conjugate. ;\nR3 : Mounting Media ; \nR4 : Phosphate Buffer Saline, pH 7.3 ± 0.1\nR5 : Evan Blue Counterstain ; \nBlotting Strip.

• 關聯藥證數量: 1

R1 : TRIS pH7.65 80 mmol/l\n L-Aspartate 240 mmol/l\n MDH(malate dehydrogenase) ≧600 U/l\n LDH(lactate dehydrogenase) ≧900 U/l\nR2 : 2-Oxoglutarate 12 mmol/l\n NADH 0.18 mmol/l

• 關聯藥證數量: 1

R1 : Urea 8.33 mmol/l (0.5 g/l)\nR2 : Urease ≧350 kU/I\nR3 : Phosphate buffer pH 8 50 mmol/l ; Sodium salicylate 62 mmol/l ; Sodium nitroprusside 3.35mmol/l ; EDTA 1 mmol/l\nR4 : Sodium hydroxide (NaOH)* 0.5 mmol/l ; Sodium hypochlorite (NaClO) 24.8 mmol/l

• 關聯藥證數量: 1

R1 Acetate buffer：35 mmol/L, pH 5.3; PEG; detergent; preservative R2 Polyclonal anti-human α1-microglobulin antibody (sheep), dependent on titer; acetate buffer：50 mmol/L, pH 5.3;preservative

• 關聯藥證數量: 1

R1 Anti-amikacin antibody (mouse monoclonal)；human-sourced material in buffer with preservative\nR2 Conjugated amikacin derivative microparticles；human-sourced material in buffer with preservative

• 關聯藥證數量: 1

R1 Anti-gentamicin monoclonal antibody (mouse) in buffer, pH 7.5.

• 關聯藥證數量: 1

R1 Anti-procainamide antibody (mouse monoclonal), G6P, NAD, preservatives and stabilizers

• 關聯藥證數量: 1

R1 Antibody Reagent\n BIS-TRIS buffer: 0.25 mol/L, pH 6.4; anti-digoxin antibodies (mouse monoclonal): ≦ 1.0 mg/L\nR2 Microsphere Reagent\n latex particles coated with digoxin

• 關聯藥證數量: 1

R1 Antibody Working Soluiton：\nSecobarbital antibody (sheep polyclonal) in buffer with bovine serum albumin and 0.09% sodium azide\nR2 Microparticle Working Solution：\nConjugated secobarbital derivative microparticles in buffer and 0.09% sodium azide

• 關聯藥證數量: 1

R1 Antibody Working Solution\n PCP antibody (mouse monoclonal) in buffer \n with bovine serum albumin and 0.09% sodium azide\nR2 Microparticle Working Solution\n Conjugated PCP derivative microparticles in buffer \n and 0.09% sodium azide

• 關聯藥證數量: 1

R1 Antibody Working Solution\n Propoxyphene antibody (goat polyclonal) in \n buffer with bovine serum albumin and 0.09% \n sodium azide\nR2 Microparticle Working Solution\n Conjugated propoxyphene derivative microparticles\n in buffer and 0.09% sodium azide\n

• 關聯藥證數量: 1

R1 Antibody Working Solution\n Propoxyphene polyclonal (goat) antibody in buffer with bovine serum albumin\nR2 Microparticle Working Solution\n Conjugated propoxyphene derivative microparticles in buffer

• 關聯藥證數量: 1

R1 Antibody reagent \nMES buffer: 0.025 mol/L; TRIS buffer: 0.015 mol/L; pH 6.2; HbA1c antibody (bovine serum): ≧0.5 mg/mL; stabilizers; preservatives (liquid)\nR2 Polyhapten reagent \nMES buffer: 0.025 mol/L; TRIS buffer: 0.015 mol/L; pH 6.2; HbA1c polyhapten: ≧8 μg/mL; stabilizers; preservatives (liquid)

• 關聯藥證數量: 1

R1 Antibody reagent \nMES buffer: 0.025 mol/L; TRIS buffer: 0.015 mol/L; pH 6.2; HbA1c antibody (ovine serum): ≧0.5 mg/mL; stabilizers; preservatives (liquid)\nR2=SR Polyhapten reagent \nMES buffer: 0.025 mol/L; TRIS buffer: 0.015 mol/L; pH 6.2; HbA1c polyhapten: ≧8 μg/mL; stabilizers; preservatives (liquid)

• 關聯藥證數量: 1

R1 Antibody reagent in vial A and B (liquid) Anti-procainamide monoclonal antibody (mouse)R2=SR Tracer reagent in vial C (liquid). Fluorescein-labeled procainamide.

• 關聯藥證數量: 1

R1 Antibody reagent in vial B (liquid).\nR2=SR Enzyme reagent in vial c (liquid).

• 關聯藥證數量: 1

R1 Antibody/substrate reagent\n Anti-N-acetylprocainamide antibody (mouse \n monoclonal), G6P and NAD in buffer\nR2 Enzyme reagent N-acetylprocainamide labeled \n with bacterial G6PDH in buffer

• 關聯藥證數量: 1

R1 Antibody/substrate reagent\n Anti-valproic acid antibody (mouse monoclonal)\n , G6P, NAD and bovine serum albumin in buffer\nR2 Enzyme reagent\n Valproic acid labeled with bacterial G6PDH, \n and bovine serum albumin in buffer

• 關聯藥證數量: 1

R1 Arsenazo-Ⅲ Dye 0.94 mmol/L Sodium Acetate 271 mmol/L

• 關聯藥證數量: 1

R1 BICIN3 buffer: 50 mmol/L, colipase ≧ 1 mg/L; Na-deoxycholate: 1.6 mmol/L; calcium chloride: 10 mmol/L\nR2 Tartrate buffer: 10 mmol/L, pH 4.0; 1,2-O-dilauryl-rac-glycero-3-glutaric acid-(6-methylresorufin) ester: 0.27 mmol/L; taurodeoxycholate: 8.8 mmol/L

• 關聯藥證數量: 1

R1 BICINa buffer: 50 mmol/L, pH 8.0; colipase ≧1 mg/L; Na-deoxycholate: 1.6 mmol/L; calcium chloride: 10 mmol/L; detergent; presrvative\nR2 Tartrate buffer: 10 mmol/L, pH4.0; 1,2-O-dilauryl-rac-glycero-3-glutaric acid-(6-methylresorufin) ester: 0.27 mmol/L; taurodeoxycholate: 8.8 mmol/L; detergent; presrvative\na) BICIN = N,N-bis(2-hydroxyethyl)-glycine

• 關聯藥證數量: 1

R1 Benzodiazepines antibody (sheep polyclonal); buffer; β-glucuronidase enzyme; bovine serum albumin (BSA); 0.09 % sodium azide\nR2 Conjugated benzodiazepine derivative microparticles; buffer; 0.09 %\n sodium azide\n

• 關聯藥證數量: 1

R1 Buffer in vial A (liquid). R2= SR Creatine phosphate in vial C (liquid), detail see labeling.

• 關聯藥證數量: 1

R1 Buffer in vial B (liquid) CAPS (3-[Cyclohexylamino]-1-propanesulfonic acid) 525 mmol/L NaOH 400 mmol/L pH 11.3nonreactive surfactantR2=SR o-Cresolphthalein complexone in vial C (liquid) o-Cresolphthalein complexone 0.5 mmol/L 8-Hydroxyquinoline 30 mmol/L pH 1.3 nonreactive stabilizer.

• 關聯藥證數量: 1

R1 Buffer, pH 8.0; rabbit serum, stabilizers and preservative.\nR2 Buffer containing latex particles coated with rabbit anti-human ferritin antibodies, stabilizers and preservative.

• 關聯藥證數量: 1

R1 Buffer,enzymes in vial A(liquid)\nR2=SR Buffer,enzymes,4-aminoantipyrine in vial C(liquid)\nActive ingredients\nR1\nHydrogen donor 1.75 mmol/L\nAscorbate oxidase 510μkat/L\n(cucumber)\nSR\n4-aminoantipyrine 5 mmol/L\nLactate oxidase(microbial) 251μkat/L\nPeroxidase(horseradish) 401μkat/L\nThe reagent contains nonreactive stabilizer and preservatives.\n

• 關聯藥證數量: 1

R1 Buffer; 0.09% sodium azide\nR2 Benzodiazepines antibody (sheep polyclonal);\n buffer; bovine serum albumin; 0.09% sodium zaide\nR3 Conjugated benzodiazepine derivative \n microparticles; buffer; 0.09% sodium azide

• 關聯藥證數量: 1

R1 Buffer; 0.09% sodium azide\nR2 PCP antibody (mouse monoclonal); buffer; bovine serum albumin; 0.09% sodium azide\nR3 Conjugated PCP derivative microparticles; buffer; 0.09% sodium azide

• 關聯藥證數量: 1

R1 Buffer; preservatives; surfactants\nR2 BCP: 526 μmol/L; buffer; preservatives; surfactant

• 關聯藥證數量: 1

R1 Buffer; preservatives\nSR NAD (yeast): ≧3 mmol/L; ADH (EC 1.1.1.1; yeast; 25℃):≧617 μkat/L (37 U/mL); stabilizers; preservatives

• 關聯藥證數量: 1

R1 Buffer\n Tris Buffer 500 mmol/, pH 11.25\n EGTA 90 μmol/l\nR2 Xylidyl Blue\n Xylidyl blue 0.28 mmol/l\n Detergent

• 關聯藥證數量: 1

R1 CAPS (3-[cyclohexylamino]-1-propanesulfonic acid): 525 mmol/L; NaOH: 400 mmol/L: pH11.3; nonreactive surfactant.\nSR o-cresolphthalein complexone: 0.5 mmol/L; 8-hydroxyquinoline: 30 mmol/L; pH 1.3; stabilizer.

• 關聯藥證數量: 1

R1 CCP~biotin (gray cap), 1 bottle, 9 mL:Biotinylated cyclic citrullinated peptides (synthetic) approx. 1.1 μg/mL, phosphate buffer 100 mmol/L, pH 5.0; preservative.

• 關聯藥證數量: 1

R1 Carbamazepine biotinylated hapten; 2-(N-Morpholino) ethanesulfonic acid (MES) buffer; pH 6.4; preservative; surfactant\nR2 Anti-carbamazepine antibody (mouse monoclonal); streptavidin coated latex microparticles: 0.08%; N-(2-Hydroxyethyl)piperazine-N-(2-ethanesulfonic acid) (HEPES) buffer; pH 7.5; preservative

• 關聯藥證數量: 1